## Abstract Three patients with locally advanced head and neck squamous cell cancer received concomitant radiation therapy (XRT) and cis‐diamminedichloroplatinum (CDDP). The dose of 6,000 rads was to be administered in two 3,000‐rad courses separated by 3 weeks. The CDDP, 30 mg/m^2^, was to be give
Concomitant CIS-platinum and radiotherapy in patients with advanced head and neck cancer: radiation therapy oncology group report
✍ Scribed by V.A. Marcial; M.A. Sarraf; E. Vélez-García; N. Figueroa-Vallés; J. Kinzie
- Publisher
- Elsevier Science
- Year
- 1984
- Tongue
- English
- Weight
- 111 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Between March 1973 and June 1979, patients with advanced operable squamous cell carcinoma of the supraglottic larynx or hypopharynx were randomly allocated to receive either preoperative radiation therapy (5,000 rad) or postoperative radiation therapy (6,000 rad). Patients with oral cavity or oropha
The Radiation Therapy Oncology Group conducts large-scale prospective, randomized trials to test new concepts in cancer patient care and provide information about pretreatment and treatment factors that may influence outcome. ## METHODS. Recursive partitioning analysis (RPA) was used to examine t